Jui-ling Hsu
Taoyuan, TNQ 33303, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A Novel HDAC6 Inhibitor Enhances the Efficacy of Paclitaxel Against Ovarian Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: June 09, 2025
Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent.
Journal: Bioorganic chemistry
Published: April 29, 2025
Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 27, 2025
Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 30, 2023
Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.
Journal: Oncology letters
Published: September 22, 2023
A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer.
Journal: The Prostate
Published: September 07, 2023
Repurposing Suan-Zao-Ren-Tang as anticancer agents in apoptotic sensitization against non-small cell lung cancer cell lines through amplification of spindle assembly checkpoint activation.
Journal: Journal of traditional and complementary medicine
Published: August 15, 2023
Mechanistic study of dual-function inhibitors targeting topoisomerase II and Rad51-mediated DNA repair pathway against castration-resistant prostate cancer.
Journal: The Prostate
Published: February 22, 2023
The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways.
Journal: Frontiers in pharmacology
Published: February 20, 2022
Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer.
Journal: Molecules (Basel, Switzerland)
Published: August 22, 2021
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity.
Journal: Bioorganic chemistry
Published: January 05, 2021
Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies.
Journal: Molecules (Basel, Switzerland)
Published: October 06, 2020
Last Updated: 09/26/2026